BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular ...

BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated ...
Frontiers

Vascular Injury in Systemic Diseases: Current Concepts and Future Perspectives Volume II

Building on the success of (Vascular Injury in Systemic Diseases: Current Concepts and Future Perspectives, we are pleased to ...
Daily Jang

Is Covid vaccine linked to increased risk of heart inflammation?

A recent UK study debunked various rumours regarding the risks of cardiac diseases linked to Covid vaccine.A study involving ...
Medscape

This Biomarker May Be More Predictive of Cardiovascular Disease Than Cholesterol

“High-sensitivity CRP has been shown to be an independent marker of risk in addition to and in some cases over and above all ...